Literature DB >> 27007449

Glioblastoma Induces Vascular Dysregulation in Nonenhancing Peritumoral Regions in Humans.

Daniel S Chow1,2, Craig I Horenstein3, Peter Canoll4, Angela Lignelli1, Elizabeth M C Hillman1,5, Christopher G Filippi1,3, Jack Grinband1.   

Abstract

OBJECTIVE: Glioblastoma is an invasive primary brain malignancy that typically infiltrates the surrounding tissue with malignant cells. It disrupts cerebral blood flow through a variety of biomechanical and biochemical mechanisms. Thus, neuroimaging focused on identifying regions of vascular dysregulation may reveal a marker of tumor spread. The purpose of this study was to use blood oxygenation level-dependent (BOLD) functional MRI (fMRI) to compare the temporal dynamics of the enhancing portion of a tumor with those of brain regions without apparent tumors.
MATERIALS AND METHODS: Patients with pathologically proven glioblastoma underwent preoperative resting-state BOLD fMRI, T1-weighted contrast-enhanced MRI, and FLAIR MRI. The contralesional control hemisphere, contrast-enhancing tumor, and peritu-moral edema were segmented by use of structural images and were used to extract the time series of these respective regions. The parameter estimates (beta values) for the two regressors and resulting z-statistic images were used as a metric to compare the similarity of the tumor dynamics to those of other brain regions.
RESULTS: The time course of the contrast-enhancing tumor was significantly different from that of the rest of the brain (p < 0.05). Similarly, the control signal intensity was significantly different from the tumor signal intensity (p < 0.05). Notably, the temporal dynamics in the peritumoral edema, which did not contain enhancing tumor, were most similar to the those of enhancing tumor than to those of control regions.
CONCLUSION: The findings show that the disruption in vascular regulation induced by a glioblastoma can be detected with BOLD fMRI and that the spatial distribution of these disruptions is localized to the immediate vicinity of the tumor and peritumoral edema.

Entities:  

Keywords:  functional imaging; glioblastoma; neurovascular coupling; resting-state functional MRI; vascular dysregulation

Mesh:

Substances:

Year:  2016        PMID: 27007449      PMCID: PMC5235899          DOI: 10.2214/AJR.15.14529

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  49 in total

1.  Impaired fMRI activation in patients with primary brain tumors.

Authors:  Zhen Jiang; Alexandre Krainik; Olivier David; Caroline Salon; Irène Troprès; Dominique Hoffmann; Nicolas Pannetier; Emmanuel L Barbier; Eduardo Ramos Bombìn; Jan Warnking; Caroline Pasteris; Stefan Chabardes; François Berger; Sylvie Grand; Christoph Segebarth; Emmanuel Gay; Jean-François Le Bas
Journal:  Neuroimage       Date:  2010-05-08       Impact factor: 6.556

Review 2.  Resting-state fMRI: a review of methods and clinical applications.

Authors:  M H Lee; C D Smyser; J S Shimony
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-30       Impact factor: 3.825

3.  Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

Authors:  Bahattin Hakyemez; Cuneyt Erdogan; Naile Bolca; Nalan Yildirim; Gokhan Gokalp; Mufit Parlak
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

4.  Modulation of cerebral arteriolar diameter by intraluminal flow and pressure.

Authors:  A C Ngai; H R Winn
Journal:  Circ Res       Date:  1995-10       Impact factor: 17.367

5.  Computed tomography and histologic limits in glial neoplasms: tumor types and selection for volumetric resection.

Authors:  P J Kelly
Journal:  Surg Neurol       Date:  1993-06

Review 6.  Coupling mechanism and significance of the BOLD signal: a status report.

Authors:  Elizabeth M C Hillman
Journal:  Annu Rev Neurosci       Date:  2014       Impact factor: 12.449

Review 7.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

8.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.

Authors:  H C Roberts; T P Roberts; R C Brasch; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

9.  Measurement of blood-brain barrier permeability with t1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms.

Authors:  Maurizio Bergamino; Laura Saitta; Laura Barletta; Laura Bonzano; Giovanni Luigi Mancardi; Lucio Castellan; Jean Louis Ravetti; Luca Roccatagliata
Journal:  ISRN Neurosci       Date:  2013-02-20

10.  Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells.

Authors:  Stacey Watkins; Stefanie Robel; Ian F Kimbrough; Stephanie M Robert; Graham Ellis-Davies; Harald Sontheimer
Journal:  Nat Commun       Date:  2014-06-19       Impact factor: 14.919

View more
  10 in total

1.  RP-Rs-fMRIomics as a Novel Imaging Analysis Strategy to Empower Diagnosis of Brain Gliomas.

Authors:  Xiaoxue Liu; Jianrui Li; Qiang Xu; Qirui Zhang; Xian Zhou; Hao Pan; Nan Wu; Guangming Lu; Zhiqiang Zhang
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

2.  Sources and implications of whole-brain fMRI signals in humans.

Authors:  Jonathan D Power; Mark Plitt; Timothy O Laumann; Alex Martin
Journal:  Neuroimage       Date:  2016-10-15       Impact factor: 6.556

3.  Local Glioma Cells Are Associated with Vascular Dysregulation.

Authors:  S G Bowden; B J A Gill; Z K Englander; C I Horenstein; G Zanazzi; P D Chang; J Samanamud; A Lignelli; J N Bruce; P Canoll; J Grinband
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

4.  Asynchrony in Peritumoral Resting-State Blood Oxygen Level-Dependent fMRI Predicts Meningioma Grade and Invasion.

Authors:  P B Wu; D S Chow; P D Petridis; M B Sisti; J N Bruce; P D Canoll; J Grinband
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-13       Impact factor: 4.966

Review 5.  Remodeling the blood-brain barrier microenvironment by natural products for brain tumor therapy.

Authors:  Xiao Zhao; Rujing Chen; Mei Liu; Jianfang Feng; Jun Chen; Kaili Hu
Journal:  Acta Pharm Sin B       Date:  2017-09-01       Impact factor: 11.413

6.  The impact of high grade glial neoplasms on human cortical electrophysiology.

Authors:  S Kathleen Bandt; Jarod L Roland; Mrinal Pahwa; Carl D Hacker; David T Bundy; Jonathan D Breshears; Mohit Sharma; Joshua S Shimony; Eric C Leuthardt
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

7.  Deep Learning Can Differentiate IDH-Mutant from IDH-Wild GBM.

Authors:  Luca Pasquini; Antonio Napolitano; Emanuela Tagliente; Francesco Dellepiane; Martina Lucignani; Antonello Vidiri; Giulio Ranazzi; Antonella Stoppacciaro; Giulia Moltoni; Matteo Nicolai; Andrea Romano; Alberto Di Napoli; Alessandro Bozzao
Journal:  J Pers Med       Date:  2021-04-09

8.  Gambogic amide inhibits angiogenesis by suppressing VEGF/VEGFR2 in endothelial cells in a TrkA-independent manner.

Authors:  Tongtong Sui; Bojun Qiu; Jiaorong Qu; Yuxin Wang; Kunnian Ran; Wei Han; Xiaozhong Peng
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

9.  BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas.

Authors:  Petros D Petridis; Craig I Horenstein; Brianna Pereira; Peter B Wu; Jorge Samanamud; Tamara Marie; Deborah Boyett; Tejaswi D Sudhakar; Sameer A Sheth; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Peter Canoll; Jack Grinband
Journal:  Neuro Oncol       Date:  2022-01-05       Impact factor: 13.029

10.  Glioma-Induced Alterations in Neuronal Activity and Neurovascular Coupling during Disease Progression.

Authors:  Mary Katherine Montgomery; Sharon H Kim; Athanassios Dovas; Hanzhi T Zhao; Alexander R Goldberg; Weihao Xu; Alexis J Yagielski; Morgan K Cambareri; Kripa B Patel; Angeliki Mela; Nelson Humala; David N Thibodeaux; Mohammed A Shaik; Ying Ma; Jack Grinband; Daniel S Chow; Catherine Schevon; Peter Canoll; Elizabeth M C Hillman
Journal:  Cell Rep       Date:  2020-04-14       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.